Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SAN - Novo Nordisk: Dominance In The Diabetes Market


SAN - Novo Nordisk: Dominance In The Diabetes Market

  • The potential continuation in diabetes and obesity trends may provide positive long-term tailwinds for Novo.
  • With health experts now urging Americans to get tested for diabetes at age 35 vs. 40, a potential increase in diagnoses could create a short-term catalyst.
  • Novo's current drug and treatment pipeline may provide the support necessary for management's goal of reaching 1/3 of the total diabetes treatment market share.
  • Between dividends and share buybacks, I believe management has shareholders' best interests in mind regarding capital distribution.

For further details see:

Novo Nordisk: Dominance In The Diabetes Market
Stock Information

Company Name: Banco Santander S.A. Sponsored ADR
Stock Symbol: SAN
Market: NYSE
Website: santander.com

Menu

SAN SAN Quote SAN Short SAN News SAN Articles SAN Message Board
Get SAN Alerts

News, Short Squeeze, Breakout and More Instantly...